JDD Buzz Series | Dietary Strategies in Psoriasis Management
Dermatology clinicians have a plethora of treatment options to consider for their psoriasis patients, from topicals to phototherapy to systemics. Yet there’s a non-prescription, adjunctive strategy that clinicians may hesitate to broach in office visits for psoriasis. Research shows dietary strategies that reduce energy intake, such as a low-calorie diet or intermittent fasting, may reduce …
Continue reading “JDD Buzz Series | Dietary Strategies in Psoriasis Management”
JDD Buzz Series | Public Interest in Hyperpigmentation
Hyperpigmentation often drives dermatology visits for patients with skin of color as an uneven skin tone can be distressing for patients. In fact, in cases where hyperpigmentation is a sequelae of an inflammatory skin condition, the hyperpigmentation can be more concerning for patients than the skin condition that caused it. Globally and in the U.S., …
Continue reading “JDD Buzz Series | Public Interest in Hyperpigmentation”
JDD Buzz Series | Psychotherapeutic Strategies in Acne Treatment | The Expert Weighs In
Topical and systemic medications are mainstays of acne treatment, targeting excess oil, clogged pores, bacteria, and inflammation. An original article published in the June Journal of Drugs in Dermatology calls for research on an adjunct acne treatment modality that addresses an unusual target: psychological stress. The authors contend psychological stress can influence acne, and psychotherapeutic …
JDD Buzz Series | Impact of Weight Loss on Soft Tissue
From news articles to social media, “Ozempic face” is commonly used to describe facial changes that accompany rapid weight loss from GLP-1 receptor agonists. A gaunt, sunken, and aged appearance is commonly attributed to Ozempic and other GLP-1s. However, bariatric surgery and dietary changes can also lead to skin laxity and loss of facial volume. …
Continue reading “JDD Buzz Series | Impact of Weight Loss on Soft Tissue”
JDD Buzz Series | Patient Perspectives on Scalp Biopsies for CCCA
Scalp biopsies are an important tool in diagnosing central centrifugal cicatricial alopecia (CCCA), especially in atypical presentations where making an accurate diagnosis through other means is challenging. Even though a biopsy-confirmed diagnosis could lead to hair-saving treatment, hair loss patients sometimes balk at the recommendation to biopsy. The authors of a brief communication published in …
Continue reading “JDD Buzz Series | Patient Perspectives on Scalp Biopsies for CCCA”
JDD April 2026 Highlights
Welcome to the April edition the JDD Highlights! Each month, we dive into the Journal of Drugs in Dermatology to bring you the most impactful research and clinical updates selected by the editor. This month’s selection reflects the rapidly evolving landscape of modern dermatology. From the diagnostic precision of Artificial Intelligence in nail disorders to …
JDD Buzz Series | Topical Nonsteroidal Therapies for Atopic Dermatitis
Topical corticosteroids have been a mainstay of frontline therapy for atopic dermatitis (AD) for more than half a century. Now therapeutic advances are challenging that standard of care. Nonsteroidal topicals — topical JAK inhibitors, aryl hydrocarbon receptor agonists, and PDE-4 inhibitors — are expanding pathways of addressing the signs and symptoms of AD. An article …
Continue reading “JDD Buzz Series | Topical Nonsteroidal Therapies for Atopic Dermatitis”
JDD March 2026 Issue Highlights
The March issue of the Journal of Drugs in Dermatology (JDD) gathers a timely, practice‑oriented collection of studies and reports selected as this month’s Editor’s Picks — spanning potential disease‑modifying implications of antiviral therapy, long‑term biologic data, evolving topical and systemic options for inflammatory skin disease, and a range of hair‑ and nail‑focused investigations that …
JDD Buzz Series | Reddit Eczema vs. AAD Guidelines
When a patient reveals they went online for health information, it’s tempting for a clinician to inwardly groan. Fears of self-diagnosis or misinformation about diagnosed conditions can make clinicians concerned when patients seek medical information through online forums and social media. Yet these virtual communities are incredibly popular, most notably Reddit and its discussion forums. …
Continue reading “JDD Buzz Series | Reddit Eczema vs. AAD Guidelines”
JDD February 2026 Issue Highlights
Welcome to “JDD February 2026 Issue Highlights,” your quick tour of this month’s Editor’s Picks from the Journal of Drugs in Dermatology, curated by the Next Steps in Derm Team. This issue pairs practical algorithms, novel therapeutics, real‑world effectiveness data, equity analyses, and procedural reports, all with immediate clinical relevance. Explore this month’s top picks …